The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2005 AND VI 23 AND IP 3
Results: 10
1
2
EMEA: for patients or for industry?
- Published in:
- 2005
- By:
- Publication type:
- Editorial
3
The relationship between productivity and health-related QOL: an exploration.
- Published in:
- 2005
- By:
- Publication type:
- journal article
4
Penny and pound wise: pharmacoeconomics from a governmental perspective.
- Published in:
- 2005
- By:
- Publication type:
- journal article
5
The Economic Impact of Neuropsychiatric Symptoms in Alzheimer’s Disease: Can Drugs Ease the Burden?
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 3, p. 227, doi. 10.2165/00019053-200523030-00004
- By:
- Publication type:
- Article
6
International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis: A Systematic Literature Review.
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 3, p. 243, doi. 10.2165/00019053-200523030-00005
- By:
- Publication type:
- Article
7
Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.
- Published in:
- 2005
- By:
- Publication type:
- journal article
8
A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain.
- Published in:
- 2005
- By:
- Publication type:
- journal article
9
The Case of Tumour Necrosis Factor-α Inhibitors in the Treatment of Rheumatoid Arthritis: A Budget Impact Analysis.
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 3, p. 289, doi. 10.2165/00019053-200523030-00008
- By:
- Publication type:
- Article
10
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.
- Published in:
- 2005
- By:
- Publication type:
- journal article